Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2258]
News [4607]
Articles [190]
Editorials [8]
Conferences [135]
elearning [9]
The leading oncology channel goes for gold
The leading oncology channel goes for gold
High-dose interleukin-2 effective in metastatic renal cell cancer pre-treated with VEGF-targeted therapies
High-dose interleukin-2 effective in metastatic renal cell cancer pre-treated with VEGF-targeted therapies
Possibilities for personalised vaccines revealed
Possibilities for personalised vaccines revealed
Researchers identify biomarker of response to new ovarian cancer drug
Researchers identify biomarker of response to new ovarian cancer drug
New computational model could design medications like chemo with fewer side effects
New computational model could design medications like chemo with fewer side effects
Personalised medicine, cancer spectrum and the immunome: ESMO 2014 highlights frontiers of cancer care
Personalised medicine, cancer spectrum and the immunome: ESMO 2014 highlights frontiers of cancer care
ESMO 2014: PD-L1 protein a possible immunotherapy target in mesothelioma
ESMO 2014: PD-L1 protein a possible immunotherapy target in mesothelioma
ESMO 2014: High-dose radiotherapy adds no survival benefit after chemotherapy and radical surgery in mesothelioma
ESMO 2014: High-dose radiotherapy adds no survival benefit after chemotherapy and radical surgery in mesothelioma
ESMO 2014: Many patients lack information about the use of targeted therapies, oncologists say
ESMO 2014: Many patients lack information about the use of targeted therapies, oncologists say
ESMO 2014: Thymidylate synthase as a predictive and prospective biomarker in lung cancer
ESMO 2014: Thymidylate synthase as a predictive and prospective biomarker in lung cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation